// September 23, 2022
Storage and Transportation of Pharmaceuticals in Brazil: Overview of regulations and ...
Proper storage and transportation of finished drug products is critical to activities in an integrated supply chain.
Medicines
// October 13, 2021
Standards Enable a Strong Medicines Supply Chain
Standards Enable a Strong Medicines Supply Chain
Standards play an important role in the global medicines supply chain, helping governments and manufacturers increase the availability of safe, quality medicines, as well as building patient and health provider trust. In fact, quality standards are a big reason why we in the U.S. can get a prescription filled at our neighborhood pharmacy and trust that the medicine we receive will be safe and work as it should.
// November 11, 2022
Latest nitrosamines recall spotlighting need to control pharmaceutical impurities ...
Revised on: January 17, 2023
// September 23, 2022
4 Drivers of Childhood Cancer Treatment Supply Chain Vulnerability ...
Persistent and long-lasting shortages of childhood cancer treatments undermine the advancements in science that have helped to increase childhood cancer survival rates to 85 percent.
// August 22, 2022
How extreme weather thousands of miles away can affect your medicines ...
Countries around the world continue to be impacted by record breaking climate events. Extreme weather has impacted major hubs where U.S. medicine is made, including India, China and Italy.
// May 13, 2022
Pharmaceutical continuous manufacturing: How USP standards and related programs suppo...
As pharmaceutical continuous manufacturing (PCM) technology captures increasing stakeholder interest as one way to help achieve this goal, USP public quality standards and related programs will remain an essential part of the solution to support quality and innovation and bolster supply chain resilience.
// April 21, 2021
USP Volunteer Profile: Developing the COVID-19 Vaccine Handling Toolkit...
USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.
// March 16, 2021
Quality Raw Materials & Collaboration Essential to mAb COVID-19 Treatment Access in L...
Access to quality raw materials and increased stakeholder collaboration are needed to help ensure availability of monoclonal antibody (mAb) treatments for COVID-19 in low- and middle-income countries (LMICs).
// March 12, 2021
Nitrosamine impurities in medicines: what’s the risk?...
In simple terms, risk is the possibility of something bad happening. It’s the uncertainty around the consequences of an activity with respect to something that we value.
Show 11 More